Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

By sjmartinez • October 16, 2023

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D'Auria G, Vazquez-Uribe R, Vaaben TH, Bongers M, Mikkonen S, Vaittinen M, Tikkanen I, Kettunen M, Klåvus A, Sehgal R, Kaminska D, Pihlajamaki J, Hanhineva K, El-Nezami H, Alexander Sommer MO, Kolehmainen M. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023 Oct 13:101823. doi: 10.1016/j.molmet.2023.101823. Epub ahead of print. PMID: 37839774.

Tags: aldafermin, Cardiology/Epi, genetically modified E. coli Nissle 1917, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, non-targeted metabolomics, omics integration, Publications, Transcriptomics

Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

Ahmed M, Zulfiqar E, Hashmi TM, Zia R, Ashraf H, Naveed MA, Ahmed R, Rana JS, Ahmed F, Greene SJ, Fudim M, Mentz RJ, Fonarow[...]

Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries and cardiovascular risk factors

Phan JP, Kinninger A, Roy SK, Bhandari M, Budoff MJ. Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries[...]

Richard Cheng, MD Appointed Associate Director of Interventional Cardiology

We are pleased to announce the appointment of Richard Cheng, MD as the new associate director of interventional cardiology (IC) in the UCLA Department of Medicine Division of Cardiology. In this capacity, Dr. Cheng will[...]